1921
Volume 93, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Samples collected in 2012 through diarrheal disease surveillance in Haiti were tested for rotavirus by enzyme immunoassay and real time RT-PCR and positive samples were genotyped. The predominant genotypes were G1P[8] (29% prevalence) and G9P[8] (21%). The observed genotype prevalence was similar to that reported previously for other Caribbean countries.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.14-0403
2015-07-08
2017-09-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/93/1/54.html?itemId=/content/journals/10.4269/ajtmh.14-0403&mimeType=html&fmt=ahah

References

  1. Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI, , 2009. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 200 (Suppl 1): S9S15.[Crossref]
  2. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, WHO-coordinated Global Rotavirus Surveillance Network; , 2012. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 12: 136141.[Crossref]
  3. de Oliveira LH, Danovaro-Holliday MC, Sanwogou NJ, Ruiz-Matus C, Tambini G, Andrus JK, , 2011. Progress in the introduction of the rotavirus vaccine in Latin America and the Caribbean: four years of accumulated experience. Pediatr Infect Dis J 30 (Suppl): S61S66.[Crossref]
  4. WHO, 2008. Estimated Rotavirus Deaths for Children Under 5 Years of Age: 2008. Available at: http://wwwwhoint/immunization/monitoring_surveillance/burden/estimates/rotavirus/en/.
  5. WHO, 2009. Rotavirus vaccines: an update. Wkly Epidemiol Rec 84: 533537.
  6. Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD, , 2012. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011–2030. Vaccine 30 (Suppl 1): A7A14.[Crossref]
  7. Linhares AC, Velazquez FR, Perez-Schael I, Saez-Llorens X, Abate H, Espinoza F, López P, Macías-Parra M, Ortega-Barría E, Rivera-Medina DM, Rivera L, Pavía-Ruz N, Nuñez E, Damaso S, Ruiz-Palacios GM, De Vos B, O'Ryan M, Gillard P, Bouckenooghe A, Human Rotavirus Vaccine Study Group; , 2008. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 371: 11811189.[Crossref]
  8. Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T, , 2007. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Revista Panam Salud Publica 21: 205216.[Crossref]
  9. Steenland MW, Joseph GA, Lucien MA, Freeman N, Hast M, Nygren BL, Leshem E, Juin S, Parsons MB, Talkington DF, Mintz ED, Vertefeuille J, Balajee SA, Boncy J, Katz MA, , 2013. Laboratory-confirmed cholera and rotavirus among patients with acute diarrhea in four hospitals in Haiti, 2012–2013. Am J Trop Med Hyg 89: 641646.[Crossref]
  10. Mijatovic-Rustempasic S, Tam KI, Kerin TK, Lewis JM, Gautam R, Quaye O, Gentsch JR, Bowen MD, , 2013. Sensitive and specific quantitative detection of rotavirus A by one-step real-time reverse transcription-PCR assay without antecedent double-stranded-RNA denaturation. J Clin Microbiol 51: 30473054.[Crossref]
  11. Hull JJ, Teel EN, Kerin TK, Freeman MM, Esona MD, Gentsch JR, Cortese MM, Parashar UD, Glass RI, Bowen MD, National Rotavirus Strain Surveillance System; , 2011. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 30 (Suppl): S42S47.[Crossref]
  12. Levy K, Hubbard AE, Eisenberg JN, , 2009. Seasonality of rotavirus disease in the tropics: a systematic review and meta-analysis. Int J Epidemiol 38: 14871496.[Crossref]
  13. Bourdett-Stanziola L, Jimenez C, Ortega-Barria E, , 2008. Diversity of human rotavirus G and P genotypes in Panama, Costa Rica, and the Dominican Republic. Am J Trop Med Hyg 79: 921924.
  14. Bourdett-Stanziola L, Ortega-Barria E, Espinoza F, Bucardo F, Jimenez C, Ferrera A, , 2011. Rotavirus genotypes in Costa Rica, Nicaragua, Honduras and the Dominican Republic. Intervirology 54: 4952.[Crossref]
  15. de Oliveira LH, Danovaro-Holliday MC, Andrus JK, de Fillipis AM, Gentsch J, Matus CR, Widdowson MA, Rotavirus Surveillance Network; , 2009. Sentinel hospital surveillance for rotavirus in Latin American and Caribbean countries. J Infect Dis 200 (Suppl 1): S131S139.[Crossref]
  16. Ribas M de L, Nagashima S, Calzado A, Acosta G, Tejero Y, Cordero Y, Piedra D, Kobayashi N, , 2011. Emergence of G9 as a predominant genotype of human rotaviruses in Cuba. J Med Virol 83: 738744.[Crossref]
  17. Banyai K, Laszlo B, Duque J, Steele AD, Nelson EA, Gentsch JR, Parashar UD, , 2012. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine 30 (Suppl 1): A122A130.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.14-0403
Loading
/content/journals/10.4269/ajtmh.14-0403
Loading

Data & Media loading...

  • Received : 30 Jun 2014
  • Accepted : 29 Mar 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error